The stock of Avadel Pharmaceuticals plc (NASDAQ:AVDL) hit a new 52-week low and has $7.50 target or 7.00% below today’s $8.06 share price. The 6 months bearish chart indicates high risk for the $320.48 million company. The 1-year low was reported on Dec, 5 by Barchart.com. If the $7.50 price target is reached, the company will be worth $22.43 million less. The stock decreased 7.04% or $0.61 during the last trading session, reaching $8.06. About 159,166 shares traded. Avadel Pharmaceuticals plc (NASDAQ:AVDL) has risen 3.59% since December 5, 2016 and is uptrending. It has underperformed by 13.11% the S&P500.
Telenav Incorporated (NASDAQ:TNAV) had an increase of 2.59% in short interest. TNAV’s SI was 257,700 shares in December as released by FINRA. Its up 2.59% from 251,200 shares previously. With 68,400 avg volume, 4 days are for Telenav Incorporated (NASDAQ:TNAV)’s short sellers to cover TNAV’s short positions. The SI to Telenav Incorporated’s float is 0.88%. It closed at $5.15 lastly. It is down 88.62% since December 5, 2016 and is uptrending. It has outperformed by 71.92% the S&P500.
Analysts await Avadel Pharmaceuticals plc (NASDAQ:AVDL) to report earnings on March, 6. After $0.09 actual earnings per share reported by Avadel Pharmaceuticals plc for the previous quarter, Wall Street now forecasts -355.56% negative EPS growth.
Avadel Pharmaceuticals PLC identifies, develops, and commercializes pharmaceutical products for primary care and sterile injectable markets in the United States, France, and Ireland. The company has market cap of $320.48 million. The companyÂ’s owns and develops drug delivery platforms, such as Micropump, a microparticulate system that allows the development of modified and/or controlled release of solid and oral dosage formulations of drugs; LiquiTime, which allows development of modified/controlled release liquid suspension formulations; Trigger Lock that allows development of abuse-deterrent modified/controlled release formulations of narcotic/opioid analgesics and other drugs susceptible to abuse; and Medusa, a hydrogel depot technology that allows the development of extended/modified release of injectable dosage formulations of drugs. It has a 8.51 P/E ratio. The Company’s lead products include Bloxiverz, a drug used in the operating room for the reversal of the effects of non-depolarizing neuromuscular blocking agents after surgery; Vazculep, a phenylephrine hydrochloride injection used to treat hypotension; and Akovaz, an ephedrine sulfate injection.
Among 4 analysts covering Telenav (NASDAQ:TNAV), 3 have Buy rating, 0 Sell and 1 Hold. Therefore 75% are positive. Telenav had 5 analyst reports since August 24, 2015 according to SRatingsIntel. FBR Capital initiated the shares of TNAV in report on Monday, October 17 with “Outperform” rating. The stock has “Buy” rating by Northland Capital on Monday, July 10. The firm earned “Buy” rating on Monday, August 24 by B. Riley & Co. As per Friday, January 20, the company rating was downgraded by Sidoti.
Investors sentiment decreased to 0.97 in Q2 2017. Its down 0.35, from 1.32 in 2017Q1. It is negative, as 5 investors sold Telenav, Inc. shares while 30 reduced holdings. 12 funds opened positions while 22 raised stakes. 18.57 million shares or 2.02% less from 18.95 million shares in 2017Q1 were reported. Ariel Investments Ltd Liability Co invested 0.21% in Telenav, Inc. (NASDAQ:TNAV). Clarivest Asset Mgmt Lc accumulated 25,000 shares. Tower Rech Cap Ltd (Trc) has invested 0% in Telenav, Inc. (NASDAQ:TNAV). Citigroup invested in 10,926 shares or 0% of the stock. Deutsche Comml Bank Ag holds 0% or 40,037 shares. Bancorporation Of Mellon holds 126,162 shares or 0% of its portfolio. Ancora Advsr Ltd Limited Liability Company stated it has 96,020 shares or 0.05% of all its holdings. Panagora Asset has 0% invested in Telenav, Inc. (NASDAQ:TNAV) for 2,441 shares. Rhumbline Advisers has 34,471 shares. National Bank & Trust Of Montreal Can holds 0% in Telenav, Inc. (NASDAQ:TNAV) or 748 shares. White Pine Cap Limited Com reported 73,050 shares or 0.23% of all its holdings. Nationwide Fund accumulated 0% or 46,300 shares. Eam Investors Limited Liability Company has invested 0.21% of its portfolio in Telenav, Inc. (NASDAQ:TNAV). Fuller And Thaler Asset Management has invested 0.02% in Telenav, Inc. (NASDAQ:TNAV). Natl Bank Of America De stated it has 1,028 shares or 0% of all its holdings.
Since June 14, 2017, it had 0 insider purchases, and 1 sale for $41,536 activity. Strambi Michael sold 5,000 shares worth $41,536.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.